Loading
H.M.W. Verheul represents Erasmus MC Cancer Institute in the Organisation of European Cancer Institutes, which lists the centre among its members in The Netherlands.
H.M.W. Verheul is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Erasmus MC Cancer Institute, its full member in The Netherlands. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.
| Title | Journal | Year |
|---|---|---|
| Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | New England Journal of Medicine | 2012 |
| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial | The Lancet Oncology | 2015 |
| RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics | Cancer Cell | 2015 |
These papers come from the OpenAlex author record for this person at their institution, taking the most cited articles with a DOI.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.